Q2 2020 Bristol-Myers Squibb Co Earnings Call

[music].

Ladies and gentlemen, once again you are currently on hold for this Bristol Myers Squibb, 2022nd quarter results Conference call. At this time, we are still assembly in today's audience and plan to be anyway. Shortly we do appreciate your patience and please remain on the line.

[music].

Yes.

Good day and welcome to the Bristol Myers Squibb, 2022nd quarter results Conference call. Today's conference is being recorded at this time I would like to turn the conference over to Mr., Tim Power Vice President Investor Relations. Please go ahead Sir.

Sites are landfill and good morning, everyone. Thanks for joining us today for our second quarter 2020 earnings call.

Joining me this morning with prepared remarks far Giovanni before you are board chair and Chief Executive Officer, and David Elkins, Our Chief Financial Officer also participating in today's call or Chris partner for our Chief commercialization Officer Dino.

President hematology in some terrible medical lots of certain head of global trunk develops.

As you look we supposed to slice the BNS that called that you can follow along with that for David and and Giovanni's remarks, but before we get Philly all lead or forward looking statements.

During this call will make statements about the cookies future plans and prospects. They constitute forward looking statements actual results may differ materially from those indicated by these forward looking statements. It's really since the various important factors, including those discussed in the company's FCC filings. These forward looking statements represent our.